Search
Descriptor English: Nandrolone Decanoate
Descriptor Spanish: Nandrolona Decanoato
Descriptor decanoato de nandrolona
Entry term(s) 17 decanoato de 17 beta hidroxiestr 4 en 3 ona
17 decanoato de 19 nor 4 androsteno 17 beta ol 3 ona
17-decanoato de 17 beta-hidroxiestr-4-en-3-ona
17-decanoato de 19-nor-4-androsteno-17 beta-ol-3-ona
decadurabolin
decadurobolin
decanoato de 19 nortestosterona
decanoato de 19-nortestosterona
retabolil
retabolyl
Scope note: Éster del ácido decanoico de la nandrolona que se usa como anabolizante para prevenir o tratar el SÍNDROME CONSUNTIVO asociado a enfermedades crónicas graves o a la infección por el VIH (SÍNDROME CONSUNTIVO POR VIH). Puede usarse también en el tratamiento de la OSTEOPOROSIS POSMENOPÁUSICA.
Descriptor Portuguese: Decanoato de Nandrolona
Descriptor French: Décanoate de nandrolone
Entry term(s): 17 beta Hydroxyestr 4 en 3 one 17 decanoate
17 beta-Hydroxyestr-4-en-3-one 17-decanoate
19 Nortestosterone Decanoate
19 nor 4 Androstene 17 beta ol 3 one 17 decanoate
19-Nortestosterone Decanoate
19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate
Decadurabolin
Decadurobolin
Retabolil
Retabolyl
Tree number(s): D04.210.500.365.415.638.500
D06.472.334.851.968.976.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077603
Scope note: Decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat WASTING SYNDROME associated with severe chronic illness or HIV infection (HIV WASTING SYNDROME). It may also be used in the treatment of POSTMENOPAUSAL OSTEOPOROSIS.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anabolic Agents
Bone Density Conservation Agents
Registry Number: H45187T098
Public MeSH Note: 2019; NANDROLONE DECANOATE was indexed under NANDROLONE/ analogs & derivatives 1971-2018
History Note: 2019 (1971)
DeCS ID: 57706
Unique ID: D000077603
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/04/09
Nandrolone Decanoate - Preferred
Concept UI M0044317
Scope note Decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat WASTING SYNDROME associated with severe chronic illness or HIV infection (HIV WASTING SYNDROME). It may also be used in the treatment of POSTMENOPAUSAL OSTEOPOROSIS.
Preferred term Nandrolone Decanoate
Entry term(s) 17 beta Hydroxyestr 4 en 3 one 17 decanoate
17 beta-Hydroxyestr-4-en-3-one 17-decanoate
19-Nortestosterone Decanoate - Related but not broader or narrower
Concept UI M000641026
Preferred term 19-Nortestosterone Decanoate
Entry term(s) 19 Nortestosterone Decanoate
19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate - Related but not broader or narrower
Concept UI M000641027
Preferred term 19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate
Entry term(s) 19 nor 4 Androstene 17 beta ol 3 one 17 decanoate
Retabolil - Narrower
Concept UI M0044313
Preferred term Retabolil
Entry term(s) Retabolyl
Decadurabolin - Narrower
Concept UI M0044314
Preferred term Decadurabolin
Entry term(s) Decadurobolin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey